These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 14282716)

  • 1. THE INTERACTION OF LSD AND SENSORY DEPRIVATION: PHYSIOLOGICAL CONSIDERATIONS.
    COHEN S; EDWARDS AE
    Recent Adv Biol Psychiatry; 1963; 6():139-44. PubMed ID: 14282716
    [No Abstract]   [Full Text] [Related]  

  • 2. The informational underload (sensory deprivation) model in contemporary psychiatry.
    Brawley P; Pos R
    Can Psychiatr Assoc J; 1967 Apr; 12(2):105-24. PubMed ID: 6040443
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychopathology and psychophysiology of minimal LSD-25 dosage; a preliminary dosage-response spectrum.
    GREINER T; BURCH NR; EDELBERG R
    AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):208-10. PubMed ID: 13497365
    [No Abstract]   [Full Text] [Related]  

  • 4. Psycho-physiological studies in altered sensory environments.
    COHEN SI; SILVERMAN AJ; SHMAVONIAN BM
    J Psychosom Res; 1962; 6():259-81. PubMed ID: 14022101
    [No Abstract]   [Full Text] [Related]  

  • 5. LYSERGIC ACID DIETHYLAMIDE (LSD-25). XXXV. COMPARISON OF EFFECT ON SIAMESE FIGHTING FISH AND GOLDFISH.
    GETTNER HH; ROLO A; ABRAMSON HA
    J Psychol; 1964 Jul; 58():57-63. PubMed ID: 14163636
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of D-lysergic acid diethylamide (LSD-25) on learning and retention.
    ARONSON H; WATERMANN CE; KLEE GD
    J Clin Exp Psychopathol Q Rev Psychiatry Neurol; 1962; 23():17-23. PubMed ID: 13862516
    [No Abstract]   [Full Text] [Related]  

  • 7. THE EFFECT OF D-LYSERGIC ACID DIETHYLAMIDE TARTRATE (LSD-25) AND D-2-BROMO LYSERGIC ACID TARTRATE (BOL-148) ON SPECIFIC CHOLINESTERASE AND MONOAMINE OXIDASE OF RAT LIVER AS POSSIBLE FACTORS IN THE MECHANISM OF HALLUCINATION. A HISTOCHEMICAL STUDY.
    NANDY K; SHANTHAVEERAPPA TR; BOURNE GH
    Acta Histochem; 1964 Apr; 17():259-67. PubMed ID: 14190338
    [No Abstract]   [Full Text] [Related]  

  • 8. Cognitive test performance under LSD-25, placebo and isolation.
    Goldberger L
    J Nerv Ment Dis; 1966 Jan; 142(1):4-9. PubMed ID: 5326508
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacology of mescaline and D-lysergic acid diethylamide (LSD).
    KOELLE GB
    N Engl J Med; 1958 Jan; 258(1):25-32. PubMed ID: 13493730
    [No Abstract]   [Full Text] [Related]  

  • 10. EFFECT OF THE ADMINISTRATION OF LYSERGIC ACID DIETHYLAMIDE (LSD) ON THE COLLOID VESICLES OF THE PARS INTERMEDIA OF THE TOAD PITUITARY.
    ITURRIZA FC; KOCH OR
    Endocrinology; 1964 Oct; 75():615-6. PubMed ID: 14211907
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of mescaline and of lysergic acid diethylamide (LSD-25) on the development of primary and secondary conditioned avoidance reflexes in rats].
    MAFFII G
    Farmaco Sci; 1959 Jul; 14():503-15. PubMed ID: 13853753
    [No Abstract]   [Full Text] [Related]  

  • 12. [D-Lysergic acid diethylamide (LSD). 2. Clinical aspects].
    GROF S; VOJTECHOVSKY M; VOTAVA Z
    Lek Veda Zahr; 1960; 11():245-51 contd. PubMed ID: 13858660
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of lysergic acid diethylamide (LSD-25) on the ERG of cold and warm blooded animals].
    MUELLER-LIMMROTH W; HARTMANN H
    Arch Int Pharmacodyn Ther; 1962 Jan; 135():57-67. PubMed ID: 14476956
    [No Abstract]   [Full Text] [Related]  

  • 14. Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide).
    ABRAMSON HA; SKLAROFSKY B; BARON MO; FREMONT-SMITH N
    AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):201-7. PubMed ID: 13497364
    [No Abstract]   [Full Text] [Related]  

  • 15. LSD--a generation later.
    Livingston M
    Hawaii Med J; 1982 Dec; 41(12):462, 464, 466 passim. PubMed ID: 6762371
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychophysiologic variables in the study of the effect of LSD-25 on cerebral blood flow and metabolism.
    PERLIN S
    Psychiatr Res Rep Am Psychiatr Assoc; 1956 Feb; (3):10-4. PubMed ID: 13310662
    [No Abstract]   [Full Text] [Related]  

  • 17. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SENSORY DEPRIVATION AND COGNITIVE DISORDER.
    INGLIS J
    Br J Psychiatry; 1965 Apr; 111():309-15. PubMed ID: 14286962
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychophysiological effects of a large non-experimental dose of LSD-25.
    Reynolds HH; Peterson GK
    Psychol Rep; 1966 Aug; 19(1):287-90. PubMed ID: 5942100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.